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Abstract
After infection with T. brucei AnTat 1.1, C57BL/6 mice lost splenic B2 B cells and lymphoid
follicles, developed poor parasite-specific antibody responses, lost weight, became anemic
and died with fulminating parasitemia within 35 days. In contrast, infected C57BL/6 mice
lacking the cytotoxic granule pore-forming protein perforin (Prf1-/-) retained splenic B2 B
cells and lymphoid follicles, developed high-titer antibody responses against many trypano-
some polypeptides, rapidly suppressed parasitemia and did not develop anemia or lose
weight for at least 60 days. Several lines of evidence show that T. brucei infection-induced
splenic B cell depletion results from natural killer (NK) cell-mediated cytotoxicity: i) B2 B
cells were depleted from the spleens of infected intact, T cell deficient (TCR-/-) and FcγRIIIa
deficient (CD16-/-) C57BL/6 mice excluding a requirement for T cells, NKT cell, or antibody-
dependent cell-mediated cytotoxicity; ii) administration of NK1.1 specific IgG2a (mAb
PK136) but not irrelevant IgG2a (myeloma M9144) prevented infection-induced B cell
depletion consistent with a requirement for NK cells; iii) splenic NK cells but not T cells or
NKT cells degranulated in infected C57BL/6 mice co-incident with B cell depletion evi-
denced by increased surface expression of CD107a; iv) purified NK cells from naïve
C57BL/6 mice killed purified splenic B cells from T. brucei infected but not uninfected mice
in vitro indicating acquisition of an NK cell activating phenotype by the post-infection B cells;
v) adoptively transferred C57BL/6 NK cells prevented infection-induced B cell population
growth in infected Prf1-/- mice consistent with in vivo B cell killing; vi) degranulated NK cells
in infected mice had altered gene and differentiation antigen expression and lost cytotoxic
activity consistent with functional exhaustion, but increased in number as infection pro-
gressed indicating continued generation. We conclude that NK cells in T. brucei infected
mice kill B cells, suppress humoral immunity and expedite early mortality.
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Author Summary
Trypanosomiasis-susceptible mammals that are infected with African trypanosomes
develop anemia, lose weight, lose immune competence and have an increased susceptibil-
ity to secondary infections. Our earlier studies in the T. b. brucei AnTat 1.1 mouse model
of African trypanosomiasis show that infection-induced loss of humoral immune compe-
tence correlates with depletion of splenic transitional, marginal zone and follicular B cells.
Here, we show that splenic B2 B cells in the infected mice acquire an NK cell activating
phenotype after trypanosome wave remission and are deleted by antibody-independent,
splenic NK cell-mediated cytotoxicity, which is a perforin dependent process. In the
absence of this killing process, i.e., in perforin gene knock out mice, T. brucei infection did
not cause depletion of splenic B cells, or disruption of splenic architecture, or anemia, or
weight loss, or early mortality and did elicit high-titer trypanosome polypeptide-specific
antibody responses. The studies show that T. brucei co-opts host NK cells to degrade the
antibody limb of the adaptive immune system and elicit life-threatening trypanosomiasis
pathology.
Introduction
Trypanosoma brucei brucei, T. congolense and T. vivax cause Animal African Trypanosomiasis,
which severely constrains cattle ranching and integrated agriculture in sub-Saharan Africa [1].
In addition, two sub-species of T. brucei, namely T. b. gambiense and T. b. rhodesiense, infect
humans causing human African trypanosomiasis [2], which threatens about 60 million people
in sub-Saharan Africa. These tsetse-transmitted protozoan parasites inhabit the blood plasma,
and in the case of T. brucei (sensu lato) and T. vivax, also the tissue fluids of their mammal
hosts. African trypanosomes evade immune elimination by antigenic variation of their
expressed variable surface glycoprotein (VSG) coat, which in T. brucei occurs in “about 0.1% of
trypanosome divisions”, and results from “differential expression of a VSG gene from an
archive of hundreds of silent VSG genes and pseudogenes” [3]. As a result of VSG antigenic
variation, African trypanosomiasis is characterized by recurring waves of parasitemia in which
dominant VSG types are cleared by VSG specific antibody and the surviving antigenic variants
seed the next parasitemic wave.
Peak levels of trypanosome parasitemia in trypanosomiasis-susceptible mammals, which
include humans, domestic ruminants, domestic ungulates, dogs and laboratory rodents, range
from<106 to>108 trypanosomes per ml blood depending on host species and parasite viru-
lence. In each parasitemic wave dominant antigenic variants are tagged for phagocytosis, and
in some species antibody and complement dependent lysis by IgM and IgG antibodies that are
specific for VSGs expressed by dominant antigenic variants [4–6]. However, infected trypano-
somiasis-susceptible hosts typically develop only short-lived, low-titer, IgG antibody responses
against VSGs and other trypanosome polypeptides [7], eventually become immunosuppressed
and less able to control new trypanosome antigenic variants and secondary infections [8–10],
develop anemia, cachexia and reproductive disorders [11–14], and often die. In contrast,
infected trypanosomiasis-resistant mammals, e.g., African Cape buffalo, rapidly constrain try-
panosome parasitemia to a level of<102 trypanosomes/ml blood, do not show signs of disease
[15–17], and accumulate trypanostatic/trypanocidal IgG antibodies against previously
expressed VSGs in their blood [17]. This raises the possibility that preservation of immune
competence in infected trypanosomiasis-susceptible hosts, particularly the sustained ability to
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make VSG-specific IgG antibodies and associated T helper cell responses, would increase their
ability to control parasitemia and decrease trypanosomiasis pathology.
B cell clonal exhaustion has been proposed as a cause of trypanosomiasis-induced suppres-
sion of humoral immune responses [18]. This view is supported by the development of lym-
phopenia in cattle and sheep with animal African trypanosomiasis [11, 19, 20] and with
ablation of bone marrow lymphopoiesis and depletion of splenic transitional, marginal zone
(MZ) cells and follicular (Fo) B cells in mice infected with T. brucei [10, 21, 22]. The loss of
these B cells, which are from the B2 B cell lineage [23, 24], severely compromises trypanosome-
and vaccine-specific antibody production [10]. Splenic B cell depletion also occurs in mice
infected with T. congolense [25] and T. vivax [26].
Splenic B2 B cell dynamics have not been studied in cattle although an infection-induced
increase in splenic B1-like B cells has been reported [27]. Analyses of peripheral blood B cell
dynamics in human patients with T. b. gambiense show a significant increase in T cell-indepen-
dent B cells and a significant decrease in T cell-dependent B cells as a percentage of total blood
lymphocytes accompanied by a significant decrease in anti-measles antibody in serum relative
to age-, gender- and habitat-matched uninfected individuals, although not of a level to compro-
mise immunity [28]. It remains possible that there is a link between the infection-induced
mechanism that causes the depletion of splenic B2 B cells in trypanosome-infected mice, and
those that prevent the development of trypanosome-specific IgG antibodies in infected cattle
[29] and cause the proportional decrease in T cell-dependent relative to T cell-independent B
cells in the peripheral blood of T. b. gambiense infected people.
We have previously shown that depletion of splenic B2 B cells in T. brucei infected mice
results from their apoptosis [10], which occurs independently of tumor necrosis factor (TNF)-,
FasL- and prostaglandin-induced death pathways [22] and is thus distinct from B cell fratricide
which arises in mice infected with the South American trypanosome T. cruzi [30]. Here we dis-
sect the cellular basis of T. brucei infection-induced B2 B cell depletion using a combination of
mutant mouse strains on the C57BL/6 background that lack various defined immune func-
tions, as well as antibody-mediated depletion of putative effector cells, effector cell phenotype
analysis, fate-mapping of fluorochrome-labeled cells after adoptive transfer, and in vitro and in
vivo B cell killing assays. These studies show that splenic B2 B cells in T. brucei-infected mice
are killed by NK cell-mediated cytotoxicity. The killing requires perforin, a pore-forming pro-
tein, which is found in cytotoxic granules of killer cells and which together with granzymes
induces target cell apoptosis [31–34]. Although cytotoxic T cells and NKT cells also mediate
perforin-dependent killing we show that they are not involved in killing the B2 B cells in T. bru-
cei infected mice. NK cells are lymphocyte-like components of the innate immune system.
They monitor cell surfaces using an array of receptors and kill target cells on which ligands for
NK cell activating receptors predominate over ligands for inhibitory receptors [35, 36]. We
show here that the B cells in T. brucei-infected mice acquire an NK cell activating phenotype.
This paper does not address the nature of the infection-induced NK cell activating ligand(s) on
B cells, but does address the fate of the activated NK cells.
Results
Infection-induced depletion of splenic B2 cells in immune system gene
knock out mice
Splenic B2 B cells (Table 1—mAb profiles; S1 Fig—gating profiles) were quantified in unin-
fected (Table 2) and infected (5 x 103 T. b. brucei Antat 1.1 i.p (Table 3) intact C57BL/6 mice
and mice lacking genes that modulate leukocyte activation and effector functions. Irrespective
of the mutation, infected mice became parasitemic (about 106 T. brucei/ml blood) by 4 days
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Table 2. Splenic B2 B cells in mutant C57BL/6 mouse strains.
C57BL/6 mouse stain (n = 3) Mean # of Cells/Spleen (+/- 1SD)
Transitional 2+3 MZB FoB
Wild type 2.5 x 106 (4.2 x 105) 1.7 x 106 (4.3 x 105) 2.2 x 107 (3.9 x 106)
Nu+/+ 1.2 x 106 (1.4 x 105) 1.8 x 106 (1.1 x 106) 2.4 x 107 (0.2 x 105)
TCR-/- 3.2 x 106 (5.5 x 105) 1.4 x 106 (1.8 x 105) 2.1 x 107 (1.9 x 106)
C3-/- 1.8 x 106 (8.0 x 105) 3.5 x 106 (8.0 x 105) 1.4 x 107 (1.8 x 106)
CD16-/- 3.2 x 106 (4.8 x 105) 3.8 x 105 (0.7 x 105) 1.8 x 107 (5.0 x 106)
MyD88-/- 2.0 x 106 (0.9 x 105) 1.9 x 106 (0.8 x 105) 8.7 x 106 (5.8 x 105)
TRIFF-/- 6.4 x 105 (0.2 x 105) 7.4 x 105 (0.7 x 105) 2.2 x 106 (1.7 x 105)
INFγ-/- 1.6 x 106 (0.5 x 105) 6.8 x 105 (2.2 x 105) 1.1 x 107 (2.5 x 106)
TNFR1-/- 1.4 x 106 (3.1 X 105) 4.3 x 105 (0.9 x 105) 1.4 x 107 (5.8 x 106)
Gal3-/- 1.8 x 106 (2.1 x 105) 8.7 x 105 (2.1 x 105) 1.5 x 107 (1.9 x 106)
Prf1-/- 4.0 x 106 (5.6 x 105) 6.1 x 105 (1.5 x 105) 2.2 x 107 (2.2 x 106)
doi:10.1371/journal.ppat.1005733.t002
Table 1. Differentiation antigen profiles of B2 B cells, NK cells and NKT cells used in multicolor flow
cytometry.
Cell Type Differentiation Antigen Expression
Transitional B cells B220+, AA4.1+, IgM+
Type 1 Transitional B cell B220+, AA4.1+, CD23-, IgM+
Type 2 Transitional B cell B220+, AA4.1+, CD23+, IgMhi
Type 3 Transitional B cell B220+, AA4.1+, CD23+, IgMlo
Marginal Zone B cell IgM+, AA4.1-, CD23lo, CD21+
Follicular B cell IgM+, AA4.1-, CD23hi, CD21+
Natural Killer cell CD3-, NK1.1+
doi:10.1371/journal.ppat.1005733.t001
Table 3. Impact of T. brucei infection on splenic B2 B cells.
C57BL/6 mouse stain* (n = 3) Fold change Log2 in splenic B2 B cells 10 days after infection of
mice with T. b. brucei AnTat 1.1 relative to uninfected mice of the
same strain (P <0.05 = signiﬁcant)
Transitional 2+3 MZB FoB
Wild type -2.4 (P = 0.026) -3.4 (p = 0.033) -1.9 (p = 0.023)
Nu+/+ -3.2 (p = 0.02) -3.5 (p = 0.02) -2.8 (p = 0.01)
TCR-/- -3.3 (p = 0.0001) -2.5(p = 0.0001) -2.8 (p = 0.0001)
C3-/- -1.9 (p = 0.24) -3.4 (p = 0.01) -3.3 (p = 0.0001)
CD16-/- -3.1 (p = 0.003) -1.0 (p = 0.05) -2.5 (p = 0.04)
MyD88-/- -1.4 (p = 0.01) -1.6 (p = 0.013) -1.2 (p = 0.005)
TRIFF-/- -1.5 (p = 0.006) -1.0 (p = 0.02) -2.0 (p = 0.004)
INFg-/- -3.0 (p = 0.04) -1.4 (p = 0.004) -1.1 (p = 0.03)
TNFR1-/- -3.0 (p = 0.05) -3.3 (p = 0.004) -1.6 (p = 0.03)
Gal3-/- -2.4 (p = 0.002) -1.8 (p = 0.009) -1.6 (p = 0.005)
Prf1-/- 0.7 (p = 0.02) 0.4 (p = 0.43) 0 (p = 0.16)
* Results are representative of at least 2 experiments per mutant stain
doi:10.1371/journal.ppat.1005733.t003
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after infection, developed peak parasitemias of between 8x107 and 2x108 T. brucei/ml blood
depending on mutant mouse strain on day 6 after infection and, with the exception of mice
lacking the gene encoding complement factor 3 (C3-/-), remitted first wave parasitemia to a
level of<106 T. brucei/ml blood between 6 and 7 days after infection. In infected C3-/- mice the
level of T. brucei parasitemia declined in a gradual fashion between 7 and 10 days after infec-
tion to reach a trough level of<106 T. brucei/ml blood indicating that C3 may facilitate
immune clearance of T. brucei, as previously shown for T. congolense [37].
Because numbers of splenic transitional, marginal zone and follicular B cells varied among
mutant C57BL/6 mice (Table 2), post infection changes in spleen cells are presented as the log2
fold change relative to uninfected mice of the same strain (Table 3). By 10 days after infection,
splenic transitional, MZ and Fo B cells (B2 B cells) were severely depleted from C57BL/6 mice
that: (i) were unmodified (Table 3, line 1; representative Facs plot—Fig 1A–1D) consistent with
earlier studies [10, 22], (ii) were homozygous for Nu gene expression (nu+/+) (Table 3, line 2)
and thus athymic and largely deficient in T cells; (iii) lacked genes encoding the β and δ chains
of the T cell antigen specific receptor (Table 3, line 3) and thus lacked all αβ and γδ T cells and
NKT cells; (iv) lacked the gene encoding complement factor 3 (C3, Table 3, line 4) and were
thus unable to mediate antibody- and complement-dependent cell lysis, and C3b- and iC3b-
dependent opsonization, (v) lacked the gene encoding CD16 (Table 3, line 5) and thus lacked
the low-affinity Fcγ receptor which is required for antibody-dependent cell-mediated cytotoxic-
ity; (vi) lacked genes encoding Toll like receptor adaptor proteins MyD88 (Table 3, line 6) and
Fig 1. FACS analysis of splenic B2 B cells in uninfected and T. bruceiANTat 1.1-infected C57BL/6 and Prf1-/-C57BL/6 mice. (A) Transitional B cells
(IgM+AA4.1+B220+) in a representative uninfected C57BL/6 mouse, (B) Transitional B cells in representative day 10 T. brucei infected C57BL/6 mouse;
(C)–Marginal zone B cells (IgM+CD21+CD23lo) and follicular B cells (IgM+CD21+CD23hi) in a representative uninfected C57BL/6 mouse, (D)Marginal zone
B cells and follicular B cells in a representative day 10 T. brucei infected C57BL/6 mice; (E)—Transitional B cells in a representative uninfected Prf1-/-
C57BL/6 mouse, (F) Transitional B cells in a representative day 10 T. brucei infected Prf1-/- C57BL/6 mouse;GMarginal zone B cells and follicular B cells in
a representative uninfected Prf1-/- C57BL/6 mouse, (H) Marginal zone B cells and follicular B cells in a representative day 10 T. brucei infected Prf1-/-
C57BL/6 mice.
doi:10.1371/journal.ppat.1005733.g001
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TRIFF (Table 3 line 7) and thus had defective TLR signaling, (vii) had a disrupted gene encoding
interferon gamma (INFγ) and made little or no interferon gamma [38] (Table 3, line 8; spleen
cell numbers and representative Facs plots—S2 Fig), (viii) lacked the gene encoding TNFR1
(Table 3, line 9) and thus lacked the lymphotoxin α-induced death pathway, and (ix) lacked the
gene encoding galectin 3 (Table 3, line 10), which is implicated in trypanosomiasis-associated
inflammation and anemia [39]. In contrast, by 10 days after infection of Prf1-/-mice with T. b.
brucei Antat 1.1, splenic transitional and marginal zone B cells increased slightly while numbers
of follicular B cells remained similar to those in uninfected mice (table 3, line 11; representative
Facs plots Fig 1E–1H). Thus, of the immune components studied, only perforin, which is
encoded by Prf1, had a non-redundant function required for the early (day 10) depletion of
transitional, MZ and Fo B cells from the spleens of T. brucei infected mice.
Pathology in intact and Prf1-/- C57BL/6 mice infected with T. b. brucei
AnTat 1.1
Parasitemia, weight loss, anemia. C57BL/6 and Prf1-/- C57BL/6 mice were infected with
5 x 103 T. brucei AnTat 1.1 ip at the same time, or sham infected by injection of PBS, and mice
were analyzed at intervals thereafter for parasitemia, weight, blood packed cell volume, number
of cells in the spleen, numbers of transitional, marginal zone and follicular B cells in the spleen,
serum trypanosome specific antibody levels and spleen structure. Both strains of infected mice
remitted first wave parasitemia between 6 and 7 days after infection. The peak level of 1st wave
parasitemia was lower in infected Prf1-/- (Fig 2A, mean 108 T. brucei/ml blood) compared to
infected intact mice (Fig 2A, mean 1.9 x 108 T. brucei/ml blood). Thereafter, parasitemia was
periodically detected (between 106 and 5x106 T. brucei/ml blood) for 60 days in the Prf1-/- mice
when the study was stopped (Fig 2A). In contrast, infected intact mice lost control of trypano-
some parasitemia by 30 days after infection and died with fulminating parasitemia by 35 days
after infection (Fig 2A). Loss of control of parasitemia in infected intact mice followed a period
of weight loss and anemia, which did not occur in the infected Prf1-/- mice (Fig 2B and 2C).
Infected Prf1-/- mice, for the most part, maintained populations of splenic Transitional Type B
cells, MZB cells and FoB cells at pre-infection levels throughout infection whereas these cell
populations were substantially depleted from the spleens of infected intact mice by day 10 after
infection and remained so thereafter (Fig 2D–2F).
Trypanosome-specific antibody responses. Infected Prf1-/- mice mounted higher-titer
IgM (Fig 3A), IgG (Fig 3B), IgG1 (Fig 3C) and IgG2a (Fig 3D) antibody responses against T.
brucei AnTat 1.1 components present in 0.5% NP40 lysate than infected intact mice during the
first 30 days after infection, as shown by ELISA. Furthermore the infected Prf1-/- mice pro-
duced antibodies, particularly IgG1 antibodies, against a wider range of trypanosome polypep-
tides in the trypanosome lysate than similarly infected intact mice, determined by Western
blotting after SDS-PAGE (Fig 3E–3G).
Spleen structure. B cell follicles, identified in cross sections of spleen as a large cluster of
B220+ cells with a rim of MOMA+ marginal zone macrophages, were numerous and similar in
distribution in uninfected C57BL/6 mice and Prf1-/- C57BL/6 mice (Fig 4A and 4B). However,
the follicles were for the most part lost from the spleens of infected intact mice by 10 days post
infection (dpi) [10] and those few follicles that remained were smaller than follicles in unin-
fected mice and had a substantially decreased presence of MOMA+ cells (Fig 4C). B cell follicles
were completely absent from the spleens of C57BL/6 mice at 30 dpi (Fig 4E), but remained
prevalent in the spleens of Prf1-/- C57BL/6 mice. Despite retaining large numbers of splenic
lymphoid follicles, there was a decreased presence and staining intensity of MOMA+ cells in
infected Prf1-/- mice (Fig 4D and 4F), which requires further investigation.
T. brucei-Induced B Cell Depletion
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Survival. T. brucei Antat 1.1 infected Prf1-/- mice lived at least twice as long as similarly
infected intact C57BL/6 mice. Despite their effective control of parasitemia, about 80% of
infected Prf1-/- mice developed ruffled fur by 70 days after infection. Autopsy of these animals
at 75 days post-infection showed that they had normal levels of blood packed cell volume, body
weight and splenic B2 B cells relative to matched control mice, but had multiple hemorrhages
of unknown etiology along the small intestine. Trypanosoma brucei AnTat 1.1-infected Prf1-/-
mice that did not develop ruffled fur were subjected to autopsy at 90 days post infection. These
mice did not have hemorrhaging of the alimentary canal or other organs, their blood packed
cell volume and splenic B2 B cell content were similar to those of age-matched uninfected
mice, and trypanosomes were not detected by microscopic examination of blood or spleen cell
suspensions although this does not preclude sustained cryptic infection.
Contribution of T cells, NKT cells and NK cells to T. b. brucei AnTat 1.1
infection-induced B cell deletion
Perforin is found in cytotoxic granules of cytotoxic T cells (CTL), NKT cells and NK cells, any
or all of which might therefore mediate depletion of splenic B2 B cells in T. brucei infected
Fig 2. Splenic B cells and parameters of infection in intact and Prf1-/- C57BL/6 mice infected for up to 30 days with T. bruceiAnTat 1.1.
Parasitemia, body weight and blood packed cell volume were monitored in uninfected C57BL/6 and Prf1-/-mice, and mice infected for 10, 20 or 30 days
with 5X103 exponentially growing T. brucei AnTat 1.1 (n = 3/group/infection time point). In addition, spleen cells were harvested, stained with mAb to define
transitional and mature B2 B cells as described in Table 1 (n = 3/group/post-infection time point, with uninfected controls processed together with infected
mice at each time point) and analyzed using flow cytometry using gates shown in S2 Fig. Results are presented as: (A) T. brucei x 106/ml blood (open
squares = Prf1-/- C57BL/6, closed circles = C57BL/6), (B) body weight in grams (closed circles = uninfected C57BL/6, open circles = infected C57BL/6,
closed triangles = uninfected Prf1-/-mice, open triangles = infected Prf1-/-mice), (C) Blood packed cell volume (PCV) (closed circles = C57BL/6 mice,
closed triangles = Prf1-/-mice) measured as the % of blood cell pellet to total volume, (D) total numbers of transitional (types T2+T3) B cells/ spleen, (E)
total numbers of Marginal Zone B cells/spleen, (F) total numbers of Follicular B cells/spleen. Data are presented as mean +/- 1 standard deviation.
Significance (*<0.05, **<0.001, ***<0.0001) was determined using one-way ANOVA and Tukey’s HSD test comparing uninfected controls to infected
individuals within a mouse strain but not between strains. Results are representative of 3 identical experiments.
doi:10.1371/journal.ppat.1005733.g002
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Fig 3. Analysis by ELISA and western blotting of trypanosome antigen specific antibodies in sera from intact and Prf1-/- C57BL/6 mice infected
for up to 30 days with T. bruceiAnTat 1.1. T. b. brucei AnTat 1.1 lysate (1 μg protein in 0.05% Np40/well) was coated on wells of an ELISA plate and
used to detect trypanosome antigen specific antibodies of: (A) IgM, (B) IgG, (C) IgG1, (D) IgG2a classes in dilutions of serum (doubling dilutions from
1:1000 to 1:54,000) from groups of uninfected (naïve) intact C57BL/6 (gray dots) and Prf1-/- C57BL/6 mice (black squares) and mice that had been
infected for 10, 20 or 30 days with T. brucei AnTat 1.1(n = 6/group). Trypanosome lysate (0.5% NP40) was subjected to SDS-PAGE, transferred to
membrane and stained with pooled serum from a group of uninfected intact or Prf1-/-mice (n = 6), or mice infected with T. brucei AnTat 1.1 for 10, 20 or 30
days as indicated (n = 6/group) to detect polypeptide-specific antibodies of: (E) IgM, (F) IgG1 and (G) IgG2a classes. Results are representative of results
obtained in individual mice of each group in 3 identical experiments.
doi:10.1371/journal.ppat.1005733.g003
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mice. However numbers of transitional, marginal zone and follicular B cells were significantly
decreased in TCR-/- mice infected for 10 days with T. b. brucei AnTat 1.1 compared to unin-
fected TCR-/- mice (Table 3 line 3, Fig 5A–5G), showing that splenic B2 B cell depletion did not
require TCR+ cells, ie., T cells or NKT cells.
mAb PK136 NK1.1 depletion. To determine whether NK cells were required for T. brucei
infection-induced B2 B cell depletion, these cells were eliminated from infected mice by admin-
istration of the NK1.1 specific monoclonal antibody PK136. A single injection ip of 500 μg
monoclonal anti-NK1.1 IgG2a (mAb PK136 [40–43]) but not 500 μg of an irrelevant IgG2a
mouse myeloma protein (M9144), resulted in the almost complete loss of NK1.1+ spleen cells
from C57BL/6 mice within 4 days and subsequent mAb PK136 administration on days 4, and
7 prolonged their depletion for 10 days (Fig 6 panel A). Splenic B2 B cells, which do not express
NK1.1, were not affected by mAb PK136 treatment (Fig 6 panels B-D, histogram 1) or by treat-
ment with the irrelevant IgG2a myeloma protein M9144. Administration of anti-NK1.1 mAb
136 but not irrelevant IgG2a myeloma protein to C57BL/6 mice 1 day prior to and on days 3
Fig 4. Distribution of B220+ and MOMA+ cells in spleens of intact and Prf1-/-mice infected with T.
bruceiAnTat 1.1. Thin sections (10 μm) of OCT embedded frozen mouse spleens, were air dried, fixed in
acetone, rehydrated and stained with anti-B220 (red) to detect B cells and anti-MOMA (green) to detect
marginal metallophilic macrophages. The slides were stained and read on the same day on a Zeiss MOT200
inverted microscope with a Zeiss apotome at 20x magnification. Scale bars, 50 micrometers. (A)Uninfected
C57BL/6 mice, (B) uninfected Prf1-/- C57BL/6 mice, (C, E) C57BL/6 mice infected for 10 and 30 days with T.
brucei AnTat 1.1, (D, F) Prf1-/- C57BL/6 mice infected for 10 and 30 days with T. brucei AnTat 1.1. Results
are representative of 5 mice studied in each group.
doi:10.1371/journal.ppat.1005733.g004
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and 7 after infection with T. b. brucei AnTat 1.1 prevented infection-induced depletion of
splenic B cells (Fig 6B–6D).
Although splenic B2 B cells are depleted from infected TCR-/- C57BL/6 mice (Fig 5), TCR-/-
mice that were administered PK136 mAb on days 0, 3 and 7 post infection with T. brucei
AnTat 1.1 retained similar numbers of splenic B2 B cells to uninfected TCR-/- mice (S3 Fig; the
study was repeated twice with the same result; control treatments with the irrelevant IgG2a
were not done). Taken together results presented in Figs 5, 6 and S3 show that NK1.1+ TCR-
cells, i.e., NK cells are required for T. brucei infection-induced depletion of splenic transitional,
MZ and Fo B cells. Depletion of splenic B2 B cells by NK cells was a result of direct NK cell-
mediated cytotoxicity rather than antibody-dependent NK cell-mediated cytotoxicity because
numbers of transitional, marginal zone and follicular B cells were significantly and substan-
tially decreased in T. brucei infected CD16-/- mice compared to uninfected CD16-/- mice
(Table 3 line 5, S4 Fig). CD16 encodes FcγRIIIa, the low affinity IgG Fc region receptor, which
is required for antibody-dependent cell-mediated cytotoxicity [44].
NK cell cytotoxic granule degranulation in infected mice
To determine whether NK cells in T. brucei infected mice express their cytolytic function, these
cells were examined for surface expression of CD107a, which is a marker of secretory lyso-
somes including cytotoxic granules. CD107a is required for delivery of perforin to NK cell
Fig 5. Splenic B cell populations in uninfected and T. bruceiAnTat 1.1-infected TCR-/- C57BL/6 mice. Splenic B cells in uninfected B6-TCR-/-
mice (n = 3) and B6-TCR-/- (n = 3) mice that had been infected with T. brucei AnTat 1.1 for 10 days were stained for surface markers used to define
transitional and mature B2 B cells as described in Table 1 and analyzed using flow cytometry. Results are presented as individual and mean +/- 1SD
numbers of: (A) Transitional 2+3 B cells/spleen, (B)MZB cells/spleen and (C) FoB cells/spleen. Significance (*p<0.05; **p<0.01) is determined using
one-way ANOVA and Tukey’s HSD test comparing uninfected controls to infected individuals. Results are representative of 3 identical experiments.
D–GRepresentative FACS plots of: (D) FoB and MZB spleen cells from an uninfected TCR-/- C57BL/6 mouse, (E) FoB and MZB spleen cells from a
day 10 infected TCR-/- C57BL/6 mouse, (F) Transitional (AA4.1+, B220+) spleen cells from an uninfected TCR-/- C57BL/6, (G) Transitional (AA4.1+,
B220+) spleen cells from an a day 10 infected TCR-/- C57BL/6 mouse.
doi:10.1371/journal.ppat.1005733.g005
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cytotoxic granules from trans-Golgi transport vesicles, and is exported onto the surface of cyto-
toxic cells when they degranulate during execution of their cytotoxic function [45–49]. The
portion of splenic NK cells expressing CD107a on their surface increased from<5% in unin-
fected mice to almost 100% at 10 days after infection with T. b. brucei AnTat 1.1 (day 10 only
shown in Fig 7A). This was accompanied by only a minimal increase in expression of CD107a
by splenic CD8 T cells and NKT cells. Binding of the CD107a-specific antibody to T and NKT
cells was constitutively high in C57BL/6 mice relative to binding to the NK cells (Fig 7B & 7C);
this was not an experimental artifact because the splenic NK, NKT and T cells were stained in
the same tube. CD107a expression also increased on NK cells harvested from the liver and
lymph nodes after parasite wave remission (day 10 post infection data shown in S5 Fig) indicat-
ing that NK cells expressed their cytotoxic function, in multiple organs. Fig 7 also shows
changes in expression of several other antigens by NK cells from infected mice, and these are
discussed later in the text.
Fig 6. Efficacy of NK1.1 cell depletion and its impact on splenic B2 B cell survival in C57BL/6 mice infected with T. bruceiAnTat 1.1. (A)
NK1.1+ CD3+ (NKT) and NK1.1+ CD3- (NK) cells in spleens of C57BL/6 mice (n = 3) administered 500ug mAb PK136 anti-NK1.1 monoclonal antibody
(upper panel) or C57BL/6 mice (n = 3) administered an irrelevant IgG2a monoclonal antibody (lower panel; MP144 Sigma) ip on days 0, 3, and 7 and
collected on day 10, (B-D)mean +/- 1 SD and individual total numbers of: (B) splenic T1 and T2 transitional type B cells, (C)marginal zone B cells and
(D) follicular B cells in uninfected or T. brucei AnTat 1.1 infected C57BL/6 mice treated with anti-NK1.1 or control mAb for 10 days. Significance
(*<0.05) was determined using one-way ANOVA and Tukey’s HSD test comparing uninfected controls to infected individuals. Results are
representative of 4 identical experiments.
doi:10.1371/journal.ppat.1005733.g006
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Fig 7. T. bruceiAnTat1.1 infection-induced changes in NK cell (CD3- NK1.1+) differentiation antigen
expression. Blue lines present results obtained with NK cells from an uninfected mouse and red lines present
results obtained with cells from a day 10 T. brucei AnTat 1.1 infected mouse. Results are representative of 3 mice
in each experimental group and of 3 identical repeat experiments. (A) CD107a splenic NK cells [CD3- NK1.1+],
(B) CD107a splenic NKT cells [CD3+ NK1.1+], (C) CD107a splenic T cells [NK1.1- CD3+] (D) NKp46 spleen, (E)
CD49b spleen, (F) Ly49 pan (IFCH) spleen, (G) Ly49H spleen, (H) CD122 spleen, (I) CD11c spleen, (J) TRAIL
spleen, (K) FasL spleen.
doi:10.1371/journal.ppat.1005733.g007
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Transfer of C57BL/6 NK cells into Prf1-/-mice
An adoptive transfer system was used to determine whether NK cells from C57BL/6 mice
cause splenic B cell depletion in T. brucei-infected Prf1-/- mice. The C57BL/6 NK cells were iso-
lated using negative selection and magnetic bead sorting (Miltenyi Corp., MACS micro beads)
from cell suspensions prepared from pooled spleens of uninfected C57BL/6 mice. A total of 2 x
106 viable NK cells were recovered/processed spleen. The isolated NK cells were labeled with e-
Fluor 670 in vitro washed in physiologic phosphate buffered saline (PBS) and injected intrave-
nously (iv) (5 x 106 NK cells/recipient mouse) into uninfected Prf1-/- mice or Prf1-/- mice that
had been infected 6 days earlier with T. b. brucei AnTat 1.1 which is 1 day prior to parasite
wave remission (Fig 2). Spleens were harvested from recipient mice 48 and 96 hours later (cor-
responding to 8 and 10 days after infection), cell suspensions made and analyzed for content of
eFluor 670 labeled NK cells and B2 B cells using multicolor flow cytometry.
Between 8% and 10% (4 to 5 x 105 cells) of transferred eFluor 670-labeled NK cells that had
been isolated from the spleens of uninfected mice were recovered from each recipient’s spleen
48hr after injection. A similar number of eFluor 670-labeled C57BL/6 NK cells were recovered
from the spleens of uninfected Prf1-/- recipients 96 hours after transfer. However no eFluor
670-labeled C57BL/6 NK cells were recovered from the infected Prf1-/- mice 96 hours after
transfer. It is unclear whether the labeled cells hat were transferred into infected recipients lost
their efluor 670 label or died in, or migrated out of, the infected spleen between 48 and 96
hours after transfer. Similar adoptive studies were attempted with efluor 670 labeled NK cells
that had been isolated from spleens of day 10 infected C57BL/6 mice. These were not recovered
from the spleens of either uninfected or day 6 infected recipient C57BL/6 mice at 24 or 48
hours after iv injection; we did not determine whether these previously activated NK cells fail
to localize to the recipients’ spleens, or localize and rapidly die.
The iv injection of naïve C57BL/6 NK cells into uninfected Prf1-/- recipients did not affect
numbers of splenic B2 B cells up to 4 days after injection. Intravenous injection of naïve
C57BL/6 NK cells into Prf1-/- mice that had been infected 6 days earlier with T. brucei had no
effect on splenic B cell numbers at day 8 after infection relative to infected mice that had been
injected iv with PBS. However, splenic B2 B cell numbers were significantly decreased at day 10
after infection relative to those in infected mice injected iv with PBS, but not relative to unin-
fected Prf1-/- mice (Fig 8). The results are consistent with modest depletion of splenic B2 B cells
in infected Prf1-/- mice by the C57BL/6 NK cells.
Direct NK cell-mediated B cell killing in vitro
To determine whether NK cells directly kill B cells from infected mice, NK cells and resting B2
B cells were isolated using negative selection and magnetic bead sorting (Miltenyi Corp.,
MACS micro beads) from the spleens of uninfected mice, and from mice infected with T. b.
brucei AnTat1.1 either 8 days earlier (for post-infection B cells) or 10 days earlier (for post-
infection NK cells). The B cells were labeled with eFluor 670 in vitro, washed in PBS and the
populations mixed at NK to B cell ratios ranging from 50:1 to 6.25:1 holding the number of tar-
get cells (B cells) constant, which is a standard killing protocol [50]. B cells were also incubated
in the absence of NK cells. The cell mixtures, in duplicate, were incubated in vitro at 37°C in a
humid atmosphere of 5% CO2 in air for 3 hours after which the vital dye 7AAD and a fixed
number of fluorescent beads was added to each culture to facilitate quantitation of viable B
cells (7AAD- IgM+ eFluor 670+) by flow cytometry. NK cells from uninfected or T. brucei
infected mice did not kill B cells from uninfected mice even at a ratio of 50 NK cells to 1 B cell
(Fig 9). However during 3 hours of incubation in vitro and at all NK cell to B cell ratios tested,
NK cells from the uninfected mice killed>50% splenic B cells isolated from mice that had been
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infected 8 days earlier with T. brucei AnTat 1.1 (Fig 9). Interestingly, NK cells from the infected
mice showed some B cell killing at a ratio of 50 NK cells to 1 B cell but lost killing activity at
lower NK cell to B cell ratios. In contrast, NK cells from uninfected mice maximally killed B
cells from infected mice even at a ratio of 6.5 NK cells/ B cell and in repeat experiments maxi-
mal killing was observed at 1 or fewer NK cells/B cell, consistent with serial killing of a magni-
tude similar to that shown by IL-2 activated human NK cells [51].
Fig 9. NK cells selectively kill splenic B cells frommice infected with T. bruceiAnTat 1.1. eFluor 670-labeled B cells from naive mice or mice
infected with T. brucei 8 days earlier (105 B cells/well) were incubated at 37°C with or without NK cells from naïve mice or mice infected with T. brucei 9
days earlier to give ratios of between 50 and 0.25 NK cells/1B cell. After 3 hr incubation viable B cells were enumerated in each well. Results are
presented as: relative viable B cell recovery, where 1 is the number of viable B cells remaining in cultures after incubation in the absence of NK cells. This
was 8 x 104 B cells from uninfected mice/well, and 5 x 104 B cells from infected mice/well). The study was repeated 3 times with similar results.
doi:10.1371/journal.ppat.1005733.g009
Fig 8. Depletion of splenic B cells in T. bruceiAnTat 1.1 infected Prf1-/-mice by adoptively transferred C57BL/6 splenic NK cells. Prf1-/- mice
were injected ip with 5x103 T. brucei Antat 1.1 (n = 6; infected) or with PBS (n = 3; uninfected). Five days later, 3 of the infected mice were injected iv., with
5x106 purified C57BL/6 splenic NK cells in 0.2ml PBS/recipient, and the other 3 infected mice were injected iv with 0.2 ml PBS/recipient. Spleens were
harvested from recipient mice 96 hours later (corresponding to 9 days after infection), cell suspensions prepared and (A) transitional Type 2 and 3 B cells,
(B) follicular B cells, and (C)marginal zone B cells quantified by multicolor flow cytometry. Significance (*<0.05, **<0.01, ***<0.001) was determined
using one-way ANOVA and Tukey’s HSD test comparing uninfected controls to infected individuals. Results are representative of 2 identical experiments.
doi:10.1371/journal.ppat.1005733.g008
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T. brucei infection-induced changes in NK cell phenotype and
transcriptome
Results presented in Fig 9 show that NK cells collected from the spleens of mice that had been
infected with T. brucei for 10 days had much lower B cell killing activity compared to NK cells
from uninfected mice consistent with exhaustion of cytolytic function by prior cytotoxic activ-
ity as denoted by increased levels of surface CD107a (Fig 7A). Day 10 post infection splenic
NK cells also differed from splenic NK cells of naïve mice in several other ways. Whereas NK
cells from uninfected mice expressed the natural cytotoxicity receptor NKp46 (Fig 7D blue)
and the integrin alpha subunit CD49b (Fig 7E blue), expression of these differentiation anti-
gens was greatly decreased on NK cells from day 10 infected mice (Fig 7D & 7E red). In addi-
tion, while about 40% of the NK cells from uninfected mice cells had high expression of
receptors for MHC class I detected by a Ly49 I F C H pan specific mAb and for m157 MCMV
protein detected by an Ly49 H specific mAb (Fig 7F & 7G blue) as previously reported [52],
expression of these receptors was greatly decreased on NK cells from day 10 infected mice (Fig
7F & 7G red). In contrast, whereas few NK cells from uninfected mice expressed the common
β chain of the IL-2R/IL-15R, CD122 (Fig 7H blue), and death ligands TRAIL (Fig 7J blue) and
Fas L (Fig 7K blue), their expression, particularly that of FASL was increased on NK cells from
day 10 infected mice (Fig 7H, 7J and 7K red). Furthermore, expression of CD11c was weak on
NK cells from uninfected mice but substantially greater on NK cells from day 10 infected mice
(Fig 7I), a characteristic that is shared with NK dendritic cells although dendritic NK cells also
express CD49b [53] distinguishing them from the splenic NK cells of day 10 infected mice.
NKp46- NK cells accumulated in the spleens of infected mice throughout 30 days of infec-
tion (Fig 10; representative FACs plots S6A–S6H Fig) and showed characteristic loss of CD49b
as well as NKp46 expression, and gain of CD107a, FasL and TRAIL expression (S7 Fig, repre-
sentative day 20 infected mouse). It is noteworthy that a small population of NKp46- CD49b-
CD107a+ NK cells is also present in the spleens of naïve mice (S8 Fig). Thus the NKp46- NK
cells that accumulate in the spleens of T. brucei infected mice might derive from these cells. To
determine whether that is the case, purified splenic NK cells (>99% NKp46+) were labeled
with efluor 670 and 5x106 injected iv into uninfected C57BL/6 mice or C57BL/6 mice that had
Fig 10. NKp46+ and NKp46- NK cells in C57BL/6 mice infected with T. bruceiAnTat 1.1 for up to 30
days.C57BL/6 mice (n = 3/group) were infected by ip inoculation with 5x103 T. brucei AnTat1.1 or sham-
infected by ip inoculation of physiologic saline. On days 0, 3, 5, 7, 10, 15, 20, and 30 after infection groups of
infected and uninfected mice were killed, spleen cell suspensions made and analyzed by multicolor flow
cytometry to identify NKp46+ and NKp46- NK cells (CD3-NK1.1+) using FACs gates shown in S6 Fig. Data
are presented as mean +/- 1 standard deviation; dark bars NKp46+ light bars NKp46-.
doi:10.1371/journal.ppat.1005733.g010
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been infected 7 days earlier with T. brucei AnTat 1.1. Recipient splenic efluor 670+ NK cells
were analyzed 48 hours later for expression of NKp46 and CD107a (Fig 9). Similar numbers
(10% of input) of efluor 670+ NK cells were recovered from the spleens of uninfected and
infected recipients. Those in uninfected recipients retained expression of NKp46+ and did not
acquire expression of CD107a-, whereas those in infected recipients had decreased levels of
NKp46 and increased expression of CD107a, both of which were similar in level of expression
to endogenous splenic NK cells in the infected mice (S9 Fig). These data suggest that NKp46-
CD49b- CD107a+ NK cells derive from NKp46+ CD49b+ CD107a- NK cells.
Transcriptome analysis. Analysis of differentiation antigen expression (Fig 7) and cyto-
toxic activity (Fig 9) of NK cells of naïve and T. brucei infected mice showed that the latter had
greatly decreased levels of NK cell receptors and minimal killing capacity consistent with repro-
gramming and functional exhaustion. Dramatic differences in gene expression by purified day
10 post-infection and naïve NK cells were also observed by comparative RNA-seq (S10 Fig).
Importantly, several of the transcribed genes that were decreased by more than log2 1.5 in
expression by NK cells in the day 10 infected mice compared to those of uninfected mice
(Table 4) are known to be critical to NK cell development and function, namely genes encoding:
i) transcription factors (EOMES and TBX21 [T-bet]) which are required for NK cell develop-
ment [54], ii) cytotoxic granule proteins (Prf1 and GZMA) which are required for cell-mediated
Table 4. Differential expression of selected genes in NK cells purified by FACS from pooled spleens
(n = 5) of mice infected 10 days earlier with 5 x 103 T. bruceiANTat 1.1E, or sham infected by adminis-
tration of PBS.
Expressed gene Log2 fold change Mean counts
EOMES (T box family transcription family member) -1.77 17,400
TBX21 (T-bet; T box family transcription factor member) -1.84 13,400
Prf1 (perforin) -1.48 4,880
GZMA (granzyme A) -1.58 221,000
GZMB (granzyme B) -0.0259 23,300
NKG7 (NK granule protein 7) -1.7 65,200
FasL -1.6 2,980
KLRA18 (Ly49) -1.92 2,690
NCR1 (NKp46) -1.8 27,500
KLRC1 (NKG2A) -1.67 6,770
KLRK1 (NKG2D) -1.71 29,900
CCL5 (rantes) -1.64 124,000
LTB (TNF beta) -1.63 6,040
IL-7Rα -1.87 2,840
IL-2Rβ/IL15Rβ -1.71 83,600
CXCR3 -1.7 5,740
IL-18 R1 -1.9 7,120
IL-18Rap (Il-18 receptor associated Protein) -1.7 6,950
IL-18bp (IL-18 binding protein) 1.93 1920
TCRαβγδ* Not expressed
C3Dγ* Not expressed
IgH* Not expressed
ITGAM (Mac-1)* Not expressed
* The absence of genes encoding T cell, B cell and Macrophage markers in the RNA-seq database indicates
the purity of isolated NK cells
doi:10.1371/journal.ppat.1005733.t004
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cytotoxicity; iii) NK cell receptors, (KLRA18 [ly49],NCR1 [NKp46], KLRC1 [NKG2a], KLRK1
[NKG2D] which regulate NK cell activation; iv) NK cell derived cytokines and chemokines
(LTB and CCL5); and v) receptors for cytokines/chemokines and associated molecules that
modulate NK cell proliferation (IL-7Rα, IL-2Rβ/IL-15Rβ, IL-18R1, IL-18RAP, CXCR3). In addi-
tion, among genes whose transcription was increased by more than log2 1.5 in expression in the
day 10 post infection NK cells compared to NK cells of uninfected mice was that for IL-18bp
(IL-18 binding protein), which prevents IL-18 engaging the IL-18R on NK cells.
Discussion
Severe depletion of splenic B2 B cells within 10 days after infection with T. b. brucei Antat 1.1 is
a property of infected C57BL/6 mice as well as other mouse strains. Several strains of mutant
C57BL/6 mice (TCR-/-, C3-/-, CD16-/-,MyD88-/-, TRIF-/-, INFγ-/-, TNFR1-/-, Gal3-/-, Prf1-/-) with
defects in innate and adaptive immunity were examined for expression of this infection-
induced, immunosuppressive trait. Only the gene encoding perforin (Prf1) had a non-redun-
dant function required for rapid depletion of the splenic B2 B cells and loss of humoral
immune function. Analyses over several weeks after infection showed that unlike T. b. brucei
AnTat 1.1-infected C57BL/6 mice, infected Prf1-/- mice retained B cell follicles, developed
high-titer IgM and IgG, particularly IgG1, antibody responses against a wide range of trypano-
some polypeptides, controlled trypanosome parasitemia, maintained their body weight and
blood packed cell volume, and survived at least twice as long as similarly infected intact mice,
which jointly are characteristics of trypanosomiasis resistance [7, 15, 29, 55, 56]. Despite the
dramatic decrease in trypanosomiasis pathology in infected Prf1-/- mice compared to infected
intact mice, perforin gene deletion is not proposed as a practical approach to generate trypano-
somiasis-resistant mammals. The mutation leaves cytotoxic T cells, NKT cells and NK cells
reliant solely on death ligand-dependent killing of target cells and consequently would decrease
their cytotoxic arsenal and increase host vulnerability to infections with intracellular patho-
gens. In our view, elucidation of the mechanism of T. brucei infection-induced, perforin-
dependent, B cell killing is required before considering strategies to prevent this without
compromising cell-mediated immunity.
Four complementary lines of evidence suggest that NK cells are solely responsible for the per-
forin-dependent depletion of splenic B cells in intact T. brucei-infected mice. Firstly, transitional
and mature B2 B cell populations were depleted from the spleens of intact mice and mice lack-
ing genes encoding both the beta and delta chains of the T cell antigen specific receptor and
thus lacking all T cells and NKT cells, but were not depleted from infected intact and TCR-/-
mice from which NK cells were removed by repeated administration of the NK1.1 specific
IgG2a mAb PK136. In contrast the B2 B cells were depleted from infected mice that were
administered an irrelevant myeloma IgG2a (done with intact C57BL/6 only). Secondly, splenic,
liver and lymph node NK cells, but not T cells or NKT cells showed greatly increased surface
expression of the cytotoxic granule degranulation marker CD107a during the period of B cell
depletion consistent with selective execution of their cytolytic function. Thirdly, NK cells from
uninfected and to a much lesser extent T. brucei-infected C57BL/6 mice killed splenic B cells
during co-culture in vitro. Importantly, NK cells from uninfected or infected C57BL/6 mice did
not kill B2 B cells from uninfected mice in vitro but did kill B2 B cells from infected mice indi-
cating acquisition by these B cells of an NK cell activating phenotype. Fourthly, naïve NK cells
that were transferred from intact C57BL/6 mice into T. brucei–infected Prf1-/-mice prevented
infection-induced expansion of splenic B2 B cells consistent with in vivo B cell depletion.
NK cells typically kill virus-infected or transformed cells but do not kill healthy lymphocytes
or other self-cells [57]. However, there are cases where this rule seems to be relaxed. Thus IL-2
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activated human NK cells have been shown to kill stromal cells and antigen presenting cells in
vitro [58]. In addition, NK cells have been shown to deplete virus-specific CD4+ T cells in mice
with acute systemic LCMV infection with resultant suppression of adaptive immunity [59, 60].
They have also been shown to exacerbate pathology in mice exposed to high dose influenza
virus infection although the mechanism is not resolved [61]. In addition, NK cells have been
shown to regulate auto- and allo-reactive lymphocytes [62, 63] by pathways that include deple-
tion of activated T cells [64, 65] and in which perforin-dependent cytolysis is implicated [66,
67]. Furthermore, several publications show that NK cells inhibit the development of antibody
responses [68–70] and can inhibit the generation of virus-specific antibody and long-lived T-
and B memory cells in a perforin-dependent manner [71]. These studies are consistent with a
role for NK cells in down-regulation of adaptive immune responses per se, and with their more
profound role in depletion of splenic B2 B cell and generalized immunosuppression in T. bru-
cei-infected mice documented here.
Splenic NK cells from uninfected mice had a substantially higher capacity to kill T. brucei
infection-modified B cells in vitro compared to NK cells isolated from the spleens of day 10
infected C57BL/6 mice. A similar T. brucei infection-induced loss of NK cell killing activity has
been reported for tumor cell targets [72]. The decreased cytotoxic activity of the day 10 post-
infection NK cells may result from their functional exhaustion following expression of cytotoxic
activity during B cell depletion, evidenced by their greatly increased plasma membrane expres-
sion of the cytotoxic granule degranulation marker CD107a. In addition, NK cells that accumu-
lated in the spleens of T. brucei infected mice after parasite wave remission had decreased
expression of NKp46, CD49b and Ly49 receptors, an inability to populate the spleen of adoptive
recipients, and decreased expression of genes that regulate NK cell development and function
relative to mature splenic NK cells of uninfected mice including EOMES, TBX21, Prf1, GZMA,
KLRA18, NCR1, KLRC1, KLRK1, IL-5Rβ, IL-18R1, IL-18Rap. Overall the data suggest, that the
NKp46-CD107a+ NK cells that accumulate in the spleens of T. brucei infected mice have
exhausted their cytotoxic potential, undergone partial reprogramming and will die rather than
revert to normal mature splenic NK cells. If so, newly arising precursor cells would be required
to sustain B2 B cell deletion throughout infection. In this regard adoptive transfer studies of
efluor 670-labelled splenic NKp46+NK cells into naïve and T. brucei infected recipients indi-
cated they were the precursors of the putative “spent NK cells” elicited by T. brucei infection,
and further studies showed that NKp46+CD107a- NK cells are sustained in the spleen through-
out infection and hence may be responsible for on-going deletion of newly arising B2 B cells.
NKp46 is an NK cell activating receptor that is important in tumor killing [73–75]. It has
been reported that aberrant CD56Dim human NK cells with decreased surface expression of
NKp46, NKp30, NKG2D and decreased cytotoxic function relative to CD56Dim NK cells of
uninfected newborns arise in the cord blood of newborns congenitally infected with T. cruzi
[76]. Thus decreased expression of NKp46 by NK cells might be an outcome of exposure to
infection-induced cytokine environments and consequently not limited to the T. brucei
infected splenic environment. NKp46- NK cells have also been shown to arise in the lungs of
mice infected with a high dose of influenza virus and to exacerbate pathology leading to
weight loss and death [61]. In addition, a loss of function mutation in the gene encoding
NKp46 has been shown to result in NKp46- NK cells that are hyper-responsive to various sti-
muli [77]. While it is possible that loss of NKp46 facilitates lymphocyte-destructive NK cell
activity in influenza virus infected mice, that is unlikely to be the case in T. brucei infected
mice because NK cells from naïve mice, which for the most part express NKp46, killed B cells
from infected mice in vitro and had much higher cytotoxic activity than NKp46- CD107a+ NK
cells from the infected mice consistent with loss of cytolytic function of NK cells that had
already degranulated.
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NK cells integrate receptor and ligand interactions that are either activating or inhibitory
[36]. Activated NK cells release cytotoxic granules at an immunological synapse [78] which
forms between the NK cell and target cell after an activating threshold is achieved by an
increase in activating ligands relative to inhibitory ligands on the target cell [79, 80]. MHC
class I is a major inhibitory ligand for NK cells [36, 81], which consequently kill virus-infected
and tumor cells that have decreased levels of MHC class I on their plasma membrane. In the
case of T. brucei-infected mice, MHC class I expression is substantially increased, not
decreased, on IgM+ cells (S11 Fig). However this does not automatically exclude loss of nega-
tive signaling through MHC class I receptors as a cause of NK cell-mediated B2 B cell destruc-
tion because splenic NK cells from day 10 T. brucei infected mice had decreased gene and
protein expression of the Ly49 family of MHC class I receptors. Despite this, there is no com-
pelling reason to consider that decreased expression of Ly49 receptors on NK cells is a require-
ment for T. brucei infection-induced B cell depletion. Thus NK cells from uninfected C57BL/6
mice, the majority of which express moderate or high levels of the Ly49 family of receptors,
selectively killed B cells from T. brucei infected mice in vitro. Instead, we propose that the
splenic B2 B cells from T. brucei-infected mice acquire potent NK cell activating ligand(s),
which co-opt(s) NK cells to kill them. Many NK cell activating and co-stimulatory ligands have
been reported [82] providing insights into possible infection-induced changes that would result
in an NK cell activating phenotype. The identity of the ligand on post-infection B cells that tags
the cells for NK cell mediated cytotoxicity is being addressed in on-going studies.
The studies presented above show that NK cells kill splenic B2 B cells in T. brucei infected
mice by cell-mediated cytotoxicity and thus have a central role in infection-induced loss of
humoral immune competence. Furthermore, the studies show that perforin-dependent cyto-
toxicity, possibly NK cell-mediated cytotoxicity, is required for development of anemia, weight
loss and early mortality consistent with greatly increased NK cell degranulation in the spleen,
liver and lymph nodes of the infected mice shown here. Further investigation is needed to iden-
tify the NK cell receptor(s) and B cell associated ligand(s) that mediate trypanosome infection-
induced B cell killing, to determine how NK cell-mediated cytotoxicity interacts with other
processes that contribute to trypanosomiasis-induced pathology [83–87], and importantly, to
determine the contribution, if any, of NK cells to trypanosomiasis-pathology in host species
other than mice, and in pathology associated with diseases in addition to African
trypanosomiasis.
Materials and Methods
Ethics statement
The study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health and Guidelines for
the Use of Laboratory Animals in Research, Teaching and Testing of the International Council
for Laboratory Animal Science. All animal studies were approved by the Institutional Animal
Care and Use Committee, University of Massachusetts, Amherst, MA01003 USA, as docu-
mented in protocol #s 2010–0028, 2013–0049 and 2013–0050.
Mice and trypanosomes
Male C57BL/6 (Taconic, Germantown, NY), B6-129S4-C3<tm1Crr>/j (C3-/-), B6-
129P2-Fcgr3tm1Sjv/J (CD16-/-), B6-Cg-Lgals3tm1/poi/J (Gal3-/-), B6-prf1tm1sdz/1 (Prf1-/-), B6-
129P2-Tcrbtm1momTcrdtm1mom/J (TCR-/-), B6-Tnfrs1atm1/mx/J (TNF R1-/-), B6.129S7-Ifngtm1ts/J
(INFγ-/-) mice were purchased from Jackson Laboratory (Bar Harbor, ME). All mice were
housed under barrier conditions for at least 1 week after arrival at the university and were used
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at 7–9 week of age. Breeding pairs of B6-MyD88-/- and B6-TRIF-/- mice were a gift from Dr.
Fitzgerald, University of Massachusetts School of Medicine (Worcester MA), were bred in the
animal facilities at UMass Amherst and were used at 7 to 9 weeks of age. Mice were infected by
intraperitoneal (i.p.) injection of 5000 exponentially growing pleomorphic Trypanosoma brucei
Antat 1.1 or sham infected by i.p., injection of Dulbecco’s Phosphate Buffered Saline (PBS;
GIBCO,Life Technologies); these parasites were derived from EATRO 1125 stock [88] and
grown from cryopreserved parasites in immunocompromised (600r from a 127 Cesium source)
C57BL/6 donors prior to injection. Parasitemia was assessed in tail blood by dilution in DPBS
and counting using a hemocytometer.
Mouse weight and packed cell volume measurements
Weight was measured using a Ohau brand digital scale. Blood packed cell volume was calcu-
lated after spinning blood in heparinized capillary tubes for 3 minutes in a hematocrit centri-
fuge (ADAMS MHCTII; BD, San Diego).
Antibodies: Flow cytometry
Avidin-APC-Cy7 (San Diego), anti-CD49b-biotin (clone MD5-1), anti-FasL-PE (clone MFL3),
anti-H2kb-PE (clone eBM2a), anti-NKp46-PE (clone 29A1.4), anti-IgM-PE (clone II/41), anti-
NK1.1-APC (clone pk136), anti-Ly49 C/I/F/H-PE (clone 14B11), anti-Ly49-FITC (clone
3D10), anti-TRAIL-biotin (clone N2B2), anti-CD11b-APC-Cy7 (clone M1/70), anti-
CD23-APC-Cy7 (clone B3B4), anti-CD23-FITC (clone B3B4), anti-CD45R (B220)-FITC
(clone RA3-6B2), anti-CD93–APC (clone AA4.1), anti-CD107a (clone 1D4B) and anti-
CD122-PE (Clone 5H4) were purchased from eBioscience (San Diego, CA). Anti-CD5-APC
(clone 53–7.3), ant-CD11c-PE (clone HL3), anti-CD21-APC (clone 7G6), and anti-CD49b
FITC were purchased from BD Biosciences (San Diego, CA). 7-amino-actinomycin D (7AAD)
was purchased from EMD Chemicals (San Diego, CA). IFA—Anti-MOMA-1(biotin) AbCam
was purchased from (Cambridge MA), avidin-FITC was purchased from BD Pharmingen (San
Diego, Ca) and eFluor 615 anti-human/mouse CD45 (B220) was purchased from eBiosciences
(SanDiego, Ca).
Flow cytometric analysis
Mice were killed by lethal CO2 inhalation and their spleens were excised and mechanically dis-
sociated in cold FACS Buffer (1.0% fetal bovine serum, FBS, [Atlanta Biologicals] in DPBS).
Cell pellets were prepared by centrifugation (500 g, 10 min, 4°C) and suspended in 10ml of
cold ammonium chloride red blood cell lysis buffer (ACK; 0.15M NH4Cl, 1.0 mM KHCO3,
0.1mMNa2-EDTA) and incubated for 4 minutes on ice. Remaining leukocytes were pelleted as
above, washed twice in DPBS and suspended in FACs buffer. Aliquots (100 μl) containing 106
cells were added to the wells of a 96 well V bottom plate, stained with combinations of specific
monoclonal antibodies against B cell, T cell and NK cell differentiation antigens (listed in
Table 1) and analyzed by multicolor flow cytometry as described by us [22]. Briefly, cells were
incubated with Fc block (anti-CD16/CD32 Fc III/II, eBioscience, San Diego, CA; 1:1000 dilu-
tion) for 20 minutes at 4°C, pelleted, resuspended in 100 μl aliquots of biotin- or fluoro-
chrome-conjugated primary antibodies (listed above) for 30 minutes at 4°C, washed twice in
cold FACs buffer, resuspended in 100 μl aliquots of FACs buffer with or without streptavidin
(SA) conjugated fluorochromes and incubated for an additional 30 minutes at 4°C. Samples
were washed twice and resuspended in 300 μl FACs buffer with 1 μg of 7AAD, a fluorescent
DNA intercalating agent that binds to DNA in membrane permeable (dead or dying) cells,
(EMD Chemicals, San Diego, CA). Analyses were performed using a flow cytometer (LSRII BD
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Biosciences, San Jose, CA) and data processed using FLOWJO software (Tree Star Inc., Ash-
land, OR) to determine the percentages of 7AAD- and where stated also 7AAD+ cells in anti-
body and fluorochrome-defined subsets. The total number of cells in each population was
determined by multiplying the percentages of subsets within a series of marker negative or pos-
itive gates by the total cell number of viable leukocytes in the donor spleen.
Immunofluorescence staining of the mouse spleen
Spleens from uninfected and infected C57BL/6 and Prf1-/- mice were embedded in OCT
(Sakura Finetek, Torrance, CA), frozen in dry ice, stored frozen at -80°C and incubated at
-20°C for 30 minutes before cryostat sectioning. Frozen sections (10) μmwere cut and adhered
to Poly-Prep slides (Sigma-Aldrich, St. Louis, MO), air dried and fixed in ice cold acetone for
10 minutes. Slides were blocked with 5% bovine serum albumin (BSA) and Fc blocker CD16/
CD32 (eBioscience) for 30 minutes and stained with biotin-conjugated antibody MOMA-1 at
room temperature for one hour. Sections were washed and treated for one hour at room tem-
perature with Avidin FITC and antibody B220. Stained sections were washed, air dried at room
temperature and mounted with ProLong Gold antifade reagent (Life Technologies) and cov-
ered with glass coverslips (Corning). All the slides were read on a Zeiss MOT200 inverted
microscope with a Zeiss apotome at 20x magnification.
NK cell depletion by mAb PK136 [41, 43]
Mice were injected intraperitoneally with 500 ug anti-NK1.1 IgG2a monoclonal antibody puri-
fied from hybridoma (PK136, ATCCManassas, Virginia) culture supernatant by Protein G
chromatography, or with an irrelevant control IgG2a immunoglobulin (M9144, Sigma-
Aldrich). Treatments were repeated on days 4 and 7 after the first injection of anti-NK1.1 and
splenic B cell, T cell and NK cell populations assessed on days 3, 7 and 10 using antibody stain-
ing and multicolor flow cytometry as described above.
Isolation of splenic B cells and NK cells, and labeling with E-fluor670
Erythrocyte depleted spleen cell suspensions were prepared as discussed for flow cytometry.
NK cells and B cells were isolated by negative selection using respectively Miltenyi kits (#130-
096-892 and #130-095-831). The yield of NK cells was 1.5% to 2.0% of input spleen cells and
>98% of these were CD3-NK1.1+ by staining and flow cytometry analysis (Becton Dickenson,
Fortessa). The yield of splenic B cells was 15% to 18% of input spleen cells from both naïve
mice and day 8 infected mice, and>98% of these cells were B220+IgM+ by staining and flow
cytometry. For tracking studies these cells were labeled with eFluor670 (eBiosciences Affime-
trix #65-0840-85) which did not affect viability.
NK cell cytotoxic assay
NK cell cytotoxicity assays were performed in 96 well V bottom plates at 37°C in a humid
atmosphere of 5% CO2 in air. Each well contained 200 μl medium (RPMI 1640 supplemented
with 10% Hyclone fetal bovine serum, Penicillin Streptomycin, L-glutamine and 0.2 μg rat
anti-mouse anti-CD40 mAb 3/23/ml medium Becton and Dickenson) and 105 eFluor
670-labelled B cells with or without NK cells to give ratios of between 50 NK cells/ 1B cell and
1 NK cell/4 B cells. Incubations were for 3 hours after which each well was inoculated with the
same number of fluorescent beads (Accudrop, Becton and Dickenson) and 7AAD prior to flow
cytometric analysis to allow determination of viable B cells (eFluor 670+ 7AAD-) relative to
bead number and thus the number of viable B cell remaining in each culture. Results are
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presented as: relative viable B cell recovery (where 1 = number of viable B cells after incubation
in the absence of NK cells).
Western blot analysis of trypanosome-polypeptide specific antibodies in
mouse serum
A pellet containing 108 T. brucei AnTat 1.1 purified from the blood of infected irradiated mice
by DEAE52 chromatography [89] and washed twice in PBS was suspended in 5 ml lysis buffer
(PBS, containing 0.5%NP40 and protease inhibitor cocktail [Complete mini tablets, Roche,
Indianapolis, IN]) and incubated at room temperature for 30 minutes. Insoluble material pres-
ent in the lysate was removed by centrifugation at 1000g for 5 mins. Protein content was deter-
mined by Bradford assay and an aliquot (600ug protein content) of trypanosome lysate was
fractionated by reducing SDS-PAGE on a 10% polyacrylamide gel in a single gel-spanning slot
and separated polypeptides were transferred to a polyvinylidene difluoride membrane using a
mini trans-blot transfer apparatus (Bio-Rad) according to the manufacturer’s protocols. The
membrane was blocked with 5% nonfat milk in 10 mM Tris, pH 8.0, 150 mMNaCl, 0.5%
Tween 20 (TBST) for 60 min, washed once with TBST, inserted in a slot blot apparatus (Mini
Protean Multi Screen II, Biorad) and serum, prepared from blood of control and trypanosome-
infected mice (1:200 dilution, 600 μl/slot), was added to individual slots and incubated at 4°C
for 2 h. Membranes were washed three times (10ml TBST, room temperature, 10 min) and
incubated with horseradish peroxidase-conjugated anti-mouse IgM, or IgG1 antibodies
(ABCAM 0.6 μg antibody/ml TBST) for 1 hour, then washed 3 times with TBST before devel-
oping with chemiluminescence substrate (ThermoPierce).
Enzyme linked immunosorbent assay (ELISA) of trypanosome-specific
antibodies
Wells in a 96 well plate (NUNC) were coated with 0.1 μg T. brucei Antat1.1E lysate (prepared
as above) in 100 μl PBS containing 0.05% NP40, washed with ELISA wash buffer (PBS + 1%
bovine serum albumin [BSA] + 0.05% TWEEN20) and non-specific protein binding sites were
blocked by incubation with 200 μl aliquots of PBS + 1% BSA. Aliquots (100 μl) of control and
post-infection mouse serum diluted in PBS were added to each well, incubated for 2 hours at
room temperature and wells were washed 3 times with ELISA wash buffer to remove unbound
serum immunoglobulins. Bound antibodies were revealed by addition of biotinylated anti-
mouse IgM or anti-mouse IgG (BD biosciences) to each well and bound second step antibody
was quantified after washing by incubation with avidin-conjugated horse radish peroxidase
(BD biosciences). Captured antibody was visualized with Ultra TMB ELISA (Thermo scien-
tific) and absorbance readings were made at 450nm, using a 96 well plate spectrophotometer.
mRNA seq
NK cells (>99.8% CD3- NK1.1+) were isolated using a fluorescence activated cell separator
from cell suspensions of pooled spleens of 5 naïve C57BL/6 mice and 5 C57BL/6 mice that had
been infected 10 days earlier with 5 x103 T. brucei Antat 1.1. Total DNAse treated RNA was
extracted from purified NK cells using a RNeasyPlus Mini Kit (Qiagen), amount of isolated
RNA estimated by on-chip electrophoresis using an Agilent RNA 6000 nano kit on an Agilent
2100 Bioanalyzer (Agilent Technologies), and its integrity confirmed by a RIN number of 9 or
greater. mRNA libraries were prepared from isolated RNA using a TruSeq Stranded mRNA
Library LT kit (Illumina) as recommended by manufacturer. Briefly, polyA containing mRNA
was isolated from total RNA, fragmented, primed for cDNA synthesis, reverse transcribed to
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cDNA using Superscript II reverse transcriptase and second strand synthesis performed using
dUTP instead of dTTP to quench 2nd strand amplification during subsequent PCR. Double
stranded (ds) cDNA was separated from the 2nd strand mix using AMPure XP beads (Beckman
Coulter), a single “A” nucleotide added at 3’ ends, the preparation end ligated with proprietary
bar coded paired end adapters each bearing a single T nucleotide at 3’ ends and unique to each
library, and tagged ds cDNA isolated using AMPure XP beads. cDNA fragments with adapter
molecules at both ends were amplified using a primer cocktail that anneals to the ends of the
adapters, the quality of the resulting library was estimated by on-chip electrophoresis (Agilent
DNA 1000 chip) on Qubit 3.0 Fluorometer (ThermoFisher Scientific) and single run sequenc-
ing (2 x 150) was performed using a NextSeq 500 mid output kit on a NextSeq 500 sequencer
(Illumina). The sequences were trimmed at the 3’ end to 125 bp using the FASTAQ Toolkit
and analyzed using RNA express in BaseSpace (Illumina); sequence alignment analysis was
performed against Mus musculus UCSC reference genes within the BaseSpace program.
Statistics
Cell population and other data obtained from infected animals and from non-infected controls
were subjected to two-tailed T tests with significant differences reported as follows: p0.05,
() p0.01, () p0.001. Differences among multiple groups were analyzed using ANOVA
and means were compared using Tukey’s honest significant difference (HSD) test when
p0.05 (GraphPad Prism v.4.0, GraphPad Software Inc. San Diego, CA).
Supporting Information
S1 Fig. Transitional and splenic mature B2 B cell gating strategy. Representative plots
obtained using spleen cells from uninfected mice stained B cell populations as described in
table 1. (A) Spleen leukocytes cells gated by side scatter [SSC] and forward scatter [FSC], (B)
viable splenocytes gated by lack of uptake of the vital dye 7AAD, (C) viable splenocytes gated
by surface staining with H2Db and IgM, (D) viable splenic B cells 7AAD- H2-Db+ IgM+ gated
as follicular B cell [FoB] and marginal zone B cells [MZB] based on expression levels of CD23
and CD21, (E) viable transitional B cells gated as 7AAD- B220+ AA4.1+, (F) viable Transitional
Type 1 B cells gated by 7AAD- B220+ CD23- IgM+, (G) viable Transitional Type 2 and 3 B cells
gated by 7AAD- B220+ CD23+ and respectively IgMlo and IgMhi.
(TIF)
S2 Fig. B2 B cell depletion in Infγ-/- mice. (A-C) Transitional B Cells (T2+T3; A), marginal
zone B cells (MZB; B) and follicular B cells (FoB; C) in spleens of uninfected (day 0) and T. bru-
cei AnTat 1.1 infected (day 10) Infγ-/- C57BL/6 mice (n = 3). Significance (<0.01m in all pan-
els) was determined using one-way ANOVA and Tukey’s HSD test comparing uninfected
controls to infected individuals. Results are representative of 2 identical experiments. FACS
plots of transitional B cells from a representative uninfected (D) and infected (E) mouse, and of
FoB and MZB cells from the same uninfected (F) and infected (G) mice.
(TIF)
S3 Fig. Impact of NK1.1 cell depletion on splenic B2 B cell survival in TCR-/- C57BL/6 mice
infected with T. brucei AnTat 1.1. TCR-/- C57BL/6 mice (n = 3/group) were administered
500ug mAb PK136 anti-NK1.1 monoclonal antibody ip on days 0, 3, and 7 after infection with
T. brucei Antat 1.1 (day 10) or after sham infection (day 0). Spleen cells were stained for surface
markers that define: (A) Transitional B cell, (B)Marginal Zone B cells, and (c) Follicular B
cells as described in Table 1 and analyzed using flow cytometry. There was no significant differ-
ence between B cell numbers in the uninfected and infected mice, determined using one-way
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ANOVA and Tukey’s HSD test. Results are representative of 2 identical experiments.
(TIF)
S4 Fig. B2 B cell depletion in CD16-/- mice. (A-C) Transitional B Cells (T1, T2, T3), (D)mar-
ginal zone B cells (MZB) and (E) follicular B cells (FoB) in spleens of uninfected (day 0) and T.
brucei AnTat 1.1 infected (day 10) CD16-/- C57BL/6 mice (n = 3). Significance (<0.05) was
determined using one-way ANOVA and Tukey’s HSD test comparing uninfected controls to
infected individuals. Results are representative of 2 identical experiments.
(TIF)
S5 Fig. CD107a expression by liver and lymph node NK cells of uninfected and T. brucei
infected mice. Representative FACS plots of CD107a expression on NK cells (NK1.1+ CD3-)
present in leukocyte cell suspensions prepared from liver (A) and lymph node (B) of a repre-
sentative uninfected mouse (blue line) and a mouse that had been infected 10 days earlier with
T. brucei AnTat 1.1 (red line).
(TIFF)
S6 Fig. FACS plots of NKp46 expression by splenic NK cells in T. brucei AnTat 1.1-infected
mice. The figure presents FACS plots of NKp46+ and NKp46- NK cells [CD3- NK1.1+] in
spleen cell suspensions of a representative: (A) uninfected mouse and mice that had been
infected for (B) 3 days, (C) 5 days, (D) 7 days, (E) 10 days, (F) 15 days, (G) 20 days, (H) 30
days following ip inoculation of 5 x 103 T. brucei AnTat 1.1.
(TIF)
S7 Fig. Splenic NK cell differentiation antigen expression at 20 days after infection with T.
brucei AnTat 1.1.Mice were infected with 5x103 T. brucei AnTat 1.1 or sham-infected by ip
inoculation of phosphate buffered saline and killed 20 days later. Spleen cells were stained with
specific mAbs and analyzed by FACS to determine the expression of CD107a, CD49b, NKp46,
FasL and TRAIL by NK cells (CD3- NK1.1+). Results from a representative infected (red lines)
and uninfected (blue lines) mouse are shown.
(TIF)
S8 Fig. Expression of CD107a by CD49b-NKp46- and CD49b+NKp46+ splenic NK cells of a
representative uninfected C57BL/6 mouse.
(TIF)
S9 Fig. Fate analysis of adoptively transferred NK cells. Splenic NK cells were purified from
C57BL/6 mice, labeled with efluor 670 and injected iv into uninfected mice or mice that had
been infected 7 days earlier with 5x103 T. brucei AnTat 1.1. After 48 hours spleen cell suspen-
sions were prepared and analyzed by multicolor flow cytometry for expression of NKp46 and
CD107a by efluor 670+ (transferred) and efluor 670- (resident) NK cells (CD3-NK1.1+). (A,B)
solid line—resident NK cells, dotted line—transferred NK cells, (C,D) solid line—resident NK
cells in an uninfected mouse, dashed line—resident NK cells in a day 9 infected mouse, dotted
line—transferred NK cells in a day 9 infected mouse.
(TIF)
S10 Fig. Summary of NK cell RNA-seq data. Transcriptome analysis of FACS purified NK
cells (CD3-NK1.1+) from pooled spleens of uninfected (n = 5) and day 10 T. brucei AnTat 1.1
infected (n = 5) mice (2 x 150bp reads Illumina).
(TIF)
S11 Fig. Expression of class I MHC on splenic IgM+ cells of uninfected and T. brucei Anta-
t1.1-infected C57BL/6 mice. Splenocytes from uninfected C57BL/6 mice and mice infected 10
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days earlier with T.brucei Antat1.1 were stained with monoclonal antibodies specific for IgM
and MHCI and analyzed by flow cytometry. Blue lines represent cells from representative unin-
fected animals and red lines represent cells from representative infected animals. Results are
representative of 3 identical experiments.
(TIF)
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